Aussie biotechs are tipped to avoid the worst of the tariff fallout
A report from Bell Potter shows that while US-facing biotechs should be on high alert, the likely impact of tariffs is manageable.
A report from Bell Potter shows that while US-facing biotechs should be on high alert, the likely impact of tariffs is manageable.
The ASX is higher in the first hour of trading on the back of strengthening oil prices, despite falls across the board in US markets overnight.
Imricor receives CE Mark certification for the Advantage-MR system under new European Medical Device Regulation as it hits world first with start of VISABL-VT trial.
Clinical stage neurodegenerative biotech Neurizon has strengthened its executive team as part of commercialisation efforts.
Momentum at Terra Metals’ Dante Reefs project is growing with upcoming catalysts including an initial maiden resource, further optimisation work and more drilling.
Arovella Therapeutics at forefront of overcoming limitations of CAR-T cell therapy for cancer with its healthy donor-derived iNKT cells.
White Cliff Minerals has had a strong day after sulphides were observed in drilling at Rae project in Canada, pointing to copper mineralisation.
While the ASX lifted 0.3pc in midday trading, the gains weren’t to last. Strength in bank and agriculture stocks staved off losses and the market ended just about flat.
GreenTech Metals will now focus drilling at its Whundo project to test the potential for near-term copper production opportunities.
Felix Gold is keeping up the pace at its Treasure Creek antimony project in Alaska with the start of a gravity survey.
Telix Pharmaceuticals has reported further “encouraging” results from its brain cancer radiotherapy program.
Perpetual Resources is paddling toward a maiden resource at its Raptor project in Brazil in light of the recent geopolitical developments.
ASX kicked off strong this morning, while Wall Street stayed wary. WiseTech climbed but energy stocks were pummelled after IEA report.
Chatter around semiconductor and pharmaceutical import tariffs weighed on US markets, leaving the ASX with an uncertain day of trading ahead.
Original URL: https://www.adelaidenow.com.au/business/stockhead/page/3